Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSTAR Study: Dexamethasone for Preventing Asthma After Rhinovirus Wheezing
NCT03889743Phase 4Recruiting
- Sponsor
- St. Olavs University Hospital
- Start
- May 2019
- Primary completion
- May 2028
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in asthma (2 arms), sponsored by St. Olavs University Hospital. Primary endpoints: Time to a new physician-confirmed wheezy episode at 24 months and Time to need for a regular controller medication for asthma at 24 months. Started May 2019; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03889743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03889743.